These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 11308133)

  • 1. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease.
    Provost TT; Watson R; Simmons-O'Brien E
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):147-69; quiz 170-2. PubMed ID: 8708014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antinuclear autoantibodies].
    Röther E; Peter HH
    Internist (Berl); 1995 Mar; 36(3):277-81. PubMed ID: 7737821
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
    Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
    [No Abstract]   [Full Text] [Related]  

  • 7. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
    Clegg DO; Williams HJ; Singer JZ; Steen VD; Schlegel S; Ziminski C; Alarcón GS; Luggen ME; Polisson RP; Willkens RF
    J Rheumatol; 1991 Sep; 18(9):1340-3. PubMed ID: 1757935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrications of connective tissue diseases.
    Mielants H; Veys EM; Verbruggen G; Coigne E; de Bussere A; Decrans L; Gabriel P; Poriau S; Raeman F; van der Jeught J
    Acta Rhumatol Belg; 1978; 2(3-4):141-62. PubMed ID: 316263
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antinuclear antibodies in rheumatology].
    Zuber M
    Z Rheumatol; 1994; 53(6):327-34. PubMed ID: 7871904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New criteria for the diagnosis of systemic lupus erythematosus].
    Font J; Cardellach F
    Med Clin (Barc); 1984 Jun; 83(3):109-11. PubMed ID: 6332956
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities of differentiation of antinuclear antibodies].
    Müller W; Rosenthal M; Stojan B
    Z Gesamte Inn Med; 1975 Oct; 30(20):665-71. PubMed ID: 766433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current immunological diagnosis of collagenoses. I. Systemic lupus erythematosus and systemic scleroderma].
    Jarzabek-Chorzelska M; Kołacińska-Strasz Z; Błaszczyk M; Chorzelski T; Jabłońska S
    Przegl Dermatol; 1987; 74(6):421-30. PubMed ID: 3330246
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinical spectrum of patients with anticentromere antibodies].
    Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
    Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunofluorescence studies in dermatology].
    Scherer R
    Med Klin; 1979 Feb; 74(5):132-43. PubMed ID: 368548
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear and anticytoplasmic antibodies. Concepts and misconceptions.
    Sontheimer RD; Deng JS; Gilliam JN
    J Am Acad Dermatol; 1983 Sep; 9(3):335-43. PubMed ID: 6415131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antinuclear antibodies, anti-SSA(Ro) and SSB(La) in diffuse connective tissue diseases].
    Assad RL; Gabriel Júnior A; Iglesias SS; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(3):103-8. PubMed ID: 3551017
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of cutaneous lupus erythematosus by immunohistochemical methods.
    Pohle EL; Tuffanelli DL
    Arch Dermatol; 1968 May; 97(5):520-6. PubMed ID: 4171670
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunofluorescent method in dermatology (review of the literature)].
    Dobzhanskiĭ SI; Tabakova LS
    Vestn Dermatol Venerol; 1974 Aug; 0(8):13-8. PubMed ID: 4611090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical usefulness of detection of serum antinuclear antibodies by the immunofluorescence method].
    Wranicz A
    Przegl Dermatol; 1971; 58(6):685-90. PubMed ID: 4945137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.